or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO F 0.00 2.47
    NVS D 0.00 1.37
    ABBV A 0.00 1.11
    RY B 0.00 1.10

    Represented by ETF Holdings

    Keywords: Eye Care Products Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Anti Diabetic Drugs Antibiotics Asset Management Products Atopic Dermatitis Autoimmune Disease Bank Banking Biopharmaceutical Biotechnology Blood Cancers Blood Test Capital Markets Services Cash Management
    Industries: Drug Manufacturers - Major Banks - Global Biotechnology

    Recent News for iShares Paris-Aligned Climate MSCI World ex USA ETF & its Holdings

    Date Stock Title
    Oct 2 NVO European Equities Close Mostly Higher in Wednesday Trading; Euro Area Unemployment Unchanged in August
    Oct 2 NVO Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
    Oct 2 ABBV AbbVie: $200 Peak (Rating Downgrade)
    Oct 2 NVS Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
    Oct 2 NVO Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
    Oct 2 ABBV AbbVie's Skyrizi And Rinvoq Deserve The Premium Growth Valuation
    Oct 2 NVO Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
    Oct 2 ABBV Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing
    Oct 2 ABBV 5 Best Dividend Growth Stocks to Buy in October
    Oct 2 ABBV Blue Shield of California sidesteps PBMs with new Humira biosimilar deal
    Oct 2 NVO Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
    Oct 2 NVO Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
    Oct 2 ABBV Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
    Oct 1 NVO Novo Nordisk (NVO) Stock Moves -0.89%: What You Should Know
    Oct 1 NVO U.S. port strike expected to have limited impact on healthcare supply chain: HHS
    Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
    Oct 1 NVS US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
    Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
    Oct 1 NVO Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
    Oct 1 NVS Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
    The index is composed of large- and mid-cap developed market equities, excluding the U.S., that are selected and weighted so that, in the aggregate, the portfolio is compatible with the objectives of the Paris Agreement by following a decarbonization trajectory, reducing exposure to climate-related transition and physical risks and increasing exposure to companies favorably positioned for the transition to a low-carbon economy. The fund generally will invest at least 90% of its assets in the component securities of its index.
    Passive Management
    Back to the Main PABD Page...